These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
458 related articles for article (PubMed ID: 1973525)
21. D2-dopamine receptor-mediated inhibition of cyclic AMP formation in striatal neurons in primary culture. Weiss S; Sebben M; Garcia-Sainz JA; Bockaert J Mol Pharmacol; 1985 Jun; 27(6):595-9. PubMed ID: 2987658 [TBL] [Abstract][Full Text] [Related]
22. Effects of buspirone on dopamine dependent behaviours in rats. Dhavalshankh AG; Jadhav SA; Gaikwad RV; Gaonkar RK; Thorat VM; Balsara JJ Indian J Physiol Pharmacol; 2007; 51(4):375-86. PubMed ID: 18476392 [TBL] [Abstract][Full Text] [Related]
23. Loss of D1/D2 dopamine receptor synergisms following repeated administration of D1 or D2 receptor selective antagonists: electrophysiological and behavioral studies. Hu XT; White FJ Synapse; 1994 May; 17(1):43-61. PubMed ID: 7913772 [TBL] [Abstract][Full Text] [Related]
24. Dopamine agonist-induced elevation of striatal acetylcholine: relationship between receptor occupancy and response in normal and denervated rat striatum. Enz A; Goldstein M; Meller E Mol Pharmacol; 1990 Apr; 37(4):560-5. PubMed ID: 1970116 [TBL] [Abstract][Full Text] [Related]
25. (-)-Stepholidine antagonizes the inhibition by D2 receptor agonists on synaptosomal tyrosine hydroylase in rat corpus striatum. Hu G; Jin GZ Zhongguo Yao Li Xue Bao; 1995 Jul; 16(4):376-9. PubMed ID: 7668115 [TBL] [Abstract][Full Text] [Related]
26. Regulation of dopamine synthesis in the medial prefrontal cortex is mediated by release modulating autoreceptors: studies in vivo. Galloway MP; Wolf ME; Roth RH J Pharmacol Exp Ther; 1986 Mar; 236(3):689-98. PubMed ID: 3081705 [TBL] [Abstract][Full Text] [Related]
27. Perinatal asphyxia induces long-term changes in dopamine D1, D2, and D3 receptor binding in the rat brain. Chen Y; Hillefors-Berglund M; Herrera-Marschitz M; Bjelke B; Gross J; Andersson K; von Euler G Exp Neurol; 1997 Jul; 146(1):74-80. PubMed ID: 9225740 [TBL] [Abstract][Full Text] [Related]
28. The effects of pertussis toxin on autoreceptor-mediated inhibition of dopamine synthesis in the rat striatum. Bean AJ; Shepard PD; Bunney BS; Nestler EJ; Roth RH Mol Pharmacol; 1988 Dec; 34(6):715-8. PubMed ID: 2974120 [TBL] [Abstract][Full Text] [Related]
29. Dopamine agonists at repeated "autoreceptor-selective" doses: effects upon the sensitivity of A10 dopamine autoreceptors. Jeziorski M; White FJ Synapse; 1989; 4(4):267-80. PubMed ID: 2603146 [TBL] [Abstract][Full Text] [Related]
30. Physiological release of striatal acetylcholine in vivo: modulation by D1 and D2 dopamine receptor subtypes. DeBoer P; Abercrombie ED J Pharmacol Exp Ther; 1996 May; 277(2):775-83. PubMed ID: 8627558 [TBL] [Abstract][Full Text] [Related]
31. Dopamine D2High receptors measured ex vivo are elevated in amphetamine-sensitized animals. Seeman P Synapse; 2009 Mar; 63(3):186-92. PubMed ID: 19086090 [TBL] [Abstract][Full Text] [Related]
33. 7-(4-[4-(2,3-Dichlorophenyl)-1-piperazinyl]butyloxy)-3,4-dihydro-2(1H)-quinolinone (OPC-14597), a new putative antipsychotic drug with both presynaptic dopamine autoreceptor agonistic activity and postsynaptic D2 receptor antagonistic activity. Kikuchi T; Tottori K; Uwahodo Y; Hirose T; Miwa T; Oshiro Y; Morita S J Pharmacol Exp Ther; 1995 Jul; 274(1):329-36. PubMed ID: 7616416 [TBL] [Abstract][Full Text] [Related]
34. Prolonged D2 antidopaminergic activity of alkylating and nonalkylating derivatives of spiperone in rat brain. Baldessarini RJ; Kula NS; Campbell A; Bakthavachalam V; Yuan J; Neumeyer JL Mol Pharmacol; 1992 Nov; 42(5):856-63. PubMed ID: 1435753 [TBL] [Abstract][Full Text] [Related]
35. Antagonism of l-stepholidine on D2 receptor-mediated inhibition of synaptosomal adenylate cyclase in rat corpus striatum. Hu G; Hu Y; Jin GZ Zhongguo Yao Li Xue Bao; 1992 Mar; 13(2):104-10. PubMed ID: 1598823 [TBL] [Abstract][Full Text] [Related]
36. R(-)2-fluoro-N-n-propylnorapomorphine: a very potent and D2-selective dopamine agonist. Baldessarini RJ; Kula NS; Gao Y; Campbell A; Neumeyer JL Neuropharmacology; 1991 Jan; 30(1):97-9. PubMed ID: 1675452 [TBL] [Abstract][Full Text] [Related]
37. Radiosynthesis and ex vivo evaluation of (R)-(-)-2-chloro-N-[1-11C-propyl]n-propylnorapomorphine. Palner M; McCormick P; Gillings N; Begtrup M; Wilson AA; Knudsen GM Nucl Med Biol; 2010 Jan; 37(1):35-40. PubMed ID: 20122666 [TBL] [Abstract][Full Text] [Related]
38. Differential effects of reserpine and tetrabenazine on rat striatal synaptosomal dopamine biosynthesis and synaptosomal dopamine pools. Kuczenski R J Pharmacol Exp Ther; 1977 May; 201(2):357-67. PubMed ID: 870679 [TBL] [Abstract][Full Text] [Related]
39. Long-term effects of S(+)N-n-propylnorapomorphine compared with typical and atypical antipsychotics: differential increases of cerebrocortical D2-like and striatolimbic D4-like dopamine receptors. Tarazi FI; Yeghiayan SK; Baldessarini RJ; Kula NS; Neumeyer JL Neuropsychopharmacology; 1997 Sep; 17(3):186-96. PubMed ID: 9272485 [TBL] [Abstract][Full Text] [Related]